[Antinuclear antibodies and lupus due to phenothiazines in 600 hospitalized patients].
D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002746:Chlorpromazine / Q000009:adverse effects; D003704:Dementia / Q000188:drug therapy; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology; D008297:Male; D008728:Methotrimeprazine / Q000009:adverse effects; D008875:Middle Aged; D011618:Psychotic Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy; D013881:Thioridazine / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000009:adverse effects
D000974:Antibodies, Antinuclear; D014150:Antipsychotic Agents; D014149:Tranquilizing Agents; D008728:Methotrimeprazine; D013881:Thioridazine; D005476:Fluphenazine; D002746:Chlorpromazine
Anticorps antinucléaires et lupus induits par les phénothiazines chez six cents malades hospitalisés